drugset / Trial / NCT00353873

Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids

NCT00353873

Phase 4 Completed 506 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will compare two treatment strategies (doubling the dose of inhaled steroids or adding a long acting beta2 agonist to the inhaled steroid at the same dose) in children not controlled by inhaled steroid alone at medium dose. The fixed combination SERETIDE 100/50 one inhalation twice daily will be compared to FLIXOTIDE 100 two inhalations twice daily.

Timeline

Start
2005-11-18
Primary completion
2006-10-26
Completion
2006-10-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified 100 ug Inhaled
Subject Fluticasone propionate Other / unclassified 200 ug Inhaled
Subject Salmeterol Other / unclassified 50 ug Inhaled

Indications